Biochemical and Biological Quality Control of Two Recombinant Human Erythropoietin Biosimilar Products

By  

Current Pharmaceutical Analysis, Vol. 13, Iss. 6, 2017-09 ,pp. : 566-573

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of the new generation recombinant factor concentrates

By Ragni Margaret V   Schlesinger Kimberly W  

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite

On the disruption of biochemical and biological assays by chemicals leaching from disposable laboratory plasticware

By Olivieri Aldo   Degenhardt Owen S.   McDonald G. Reid   Narang Deepak   Paulsen Isabelle M.   Kozuska Janna L.   Holt Andrew  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 697-703

NRC Research Press

Access to resources Recommend Favorite

The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema

By Cicardi Marco   Zingale Lorenza Chiara   Zanichelli Andrea   Deliliers Daniela Lambertenghi   Caccia Sonia  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3173-3181

Informa Healthcare

Access to resources Recommend Favorite

The Safety of Herbal Medicinal Products Derived from Echinacea Species: A Systematic Review

By Huntley Alyson L.   Joanna Thompson Coon   Ernst Edzard  

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 387-400

Adis International

Access to resources Recommend Favorite